EVP Global Business Development and Chief Commercial Officer
Andrew Copestake joined TFS as Chief Commercial Officer and Executive Vice President Business Development in 2018 and leads the global business development organization.
Andrew is an entrepreneurial, commercially focused, senior executive with over 25 years’ experience in the pharmaceutical, biotechnology and CRO industry.
Previous roles have included a number of senior leadership positions in business development and general management, including six years as CEO of a Swedish biotechnology company.
The majority of Andrew’s experience has been in international roles and he has lived and worked in the UK, US, Japan, Sweden and the Netherlands. He has managed diverse business development teams, and is proud of his record of achieving growth.
Andrew has proven leadership skills with an ability to manage businesses through significant change whilst achieving key operational and financial performance targets.
Andrew holds a PhD in Sport & Exercise Physiology from Loughborough University and a BSc (Hons) in Applied Biology from East London University. He is a Fellow of the Royal Society of Medicine.
Andrew will be based out of the TFS offices in London.